Hepa Merz Syrup 120ml

About Hepa Merz Syrup 120ml

Hepa Merz Syrup Uses

• Treatment of hepatic encephalopathy reducing elevated ammonia levels in blood.
• Liver support in chronic hepatitis and cirrhosis.
• Management of fatty liver disease and hepatic steatosis.
• Support for liver regeneration following hepatic injury or disease.
• Adjunctive therapy for portal hypertension and liver dysfunction.

Hepa Merz Syrup Benefits

• Promotes ammonia detoxification by stimulating the urea cycle.
• Supports hepatocyte energy production through citric acid cycle activation.
• Improves liver cell regeneration and restoration of hepatic function.
• Reduces hyperammonemia related neurological symptoms.
• Well-tolerated amino acid combination with minimal side effects.

What Experts Say

L-Ornithine and L-Aspartate (LOLA) are endogenous amino acids essential for ammonia detoxification. L-Ornithine stimulates the hepatic urea cycle by providing nitrogen-accepting molecules for ammonia conversion. L-Aspartate supplies intermediates for both the urea cycle and glutamine synthesis providing dual ammonia elimination pathways. Together these amino acids reduce serum ammonia levels which are elevated in liver disease causing hepatic encephalopathy. The amino acid combination also participates in the citric acid cycle enhancing ATP production needed for hepatocyte energy and regeneration.

Pharmacokinetically, oral L-Ornithine and L-Aspartate are absorbed in the small intestine with peak plasma concentrations within 1 to 2 hours. The amino acids rapidly enter hepatocytes where they function as substrates in ammonia metabolism. The urea cycle amplification begins within hours of oral administration. Hepatic extraction is efficient reducing systemic amino acid levels while enhancing local urea production. Urea is excreted renally providing persistent ammonia reduction. Clinical efficacy becomes apparent within days of consistent dosing.

Clinical efficacy studies demonstrate LOLA syrup effectively reduces elevated ammonia levels in hepatic encephalopathy patients. Plasma ammonia reductions of 20 to 40 percent occur with regular syrup administration. Neurological symptoms including confusion lethargy and asterixis improve with normalized ammonia levels. The amino acid supplementation proves beneficial in chronic cirrhosis and portal hypertension management. Long-term studies support sustained benefit with improved liver function markers and reduced encephalopathy episodes.

Drug Class

• Amino Acid Supplement, Hepatoprotective Agent

Packaging and Quantity

• Bottle containing 120 ml of syrup providing 300 mg of L-Ornithine L-Aspartate per 5 ml dose.

When Not to Use Hepa Merz

• Known hypersensitivity to L-Ornithine, L-Aspartate, or any component of the syrup.
• Severe renal impairment or end-stage kidney disease.
• Hyperammonemia of non-hepatic origin without medical evaluation.
• Untreated or uncontrolled infections in liver disease patients.

Hepa Merz Syrup 120ml formula

• L-Ornithine + L-Aspartate

Available forms

• Syrup
• Granules

How to use Hepa Merz Syrup 120ml?

• Shake the bottle well before each use.
• Use the provided measuring cup or spoon for accurate dosing.
• Typical adult dose is 30 ml twice daily or 5 ml twice daily as directed by physician.
• Can be taken with or after food to minimize stomach upset.
• Continue taking regularly as directed for optimal liver support.
• Do not exceed the recommended dose without medical consultation.

Drug Interactions

Hepa Merz syrup may interact with various medications affecting efficacy or safety:

• Medications affecting kidney function: NSAIDs, ACE inhibitors, diuretics may alter ammonia excretion; monitor renal function.
• Protein restriction diets: Amino acid supplementation should be coordinated with dietary protein management.
• Other hepatoprotective agents: Concurrent use may provide additive benefits; coordinate with healthcare provider.
• Lactose-containing medications: In hepatic encephalopathy patients, lactose therapy coordination is important.

Risks and warnings

• Renal function: Ammonia excretion depends on kidney function; monitor renal status in chronic liver disease.
• Ammonia rebound: Discontinuing therapy without medical guidance may cause ammonia rebound.
• Infection management: Active infections should be treated promptly as they worsen hepatic encephalopathy.
• Electrolyte balance: Monitor serum electrolytes as liver disease affects sodium and potassium balance.
• Pregnancy: Use with medical guidance; amino acid supplementation is generally considered safe.
• Breastfeeding: Small amounts pass into breast milk; generally considered safe during breastfeeding.
• Regular monitoring: Periodic liver function tests and ammonia levels help assess therapy effectiveness.

Hepa Merz Syrup Side Effects

Hepa Merz syrup is generally well-tolerated with minimal adverse effects. Following are rarely reported adverse effects:

• Mild nausea or gastrointestinal discomfort.
• Loss of appetite.
• Mild diarrhea.
• Headache.

Serious side effects requiring immediate medical attention:

• Severe allergic reaction with rash or angioedema.
• Signs of worsening liver dysfunction.
• Severe gastrointestinal bleeding.

Storage Conditions

• Store at room temperature between 15 to 25 degrees Celsius.
• Keep away from direct sunlight and excessive heat.
• Protect from moisture in a tightly sealed bottle.
• Keep bottle cap tightly closed after each use.
• Keep out of reach of children and pets.
• Do not use after the expiration date on the packaging.